Men, have you had your MANogram yet?
According to Dr. Robert Princenthal, Medical Director for RadNet’s Prostate MRI Program, this study is part of the growing evidence to support what he calls the “man-o-gram,” or as he explains, “prostate MRI plus PSA screening (a blood test not offered at our locations, but available at a local lab through your referring physician), in order to optimize early detection.”
RadNet Participates in Exciting Clinical Trials to Evaluate and Stage Prostate Cancer
RadNet’s Research Division has been participating in two clinical trials of a prostate-specific Positron Emission Tomography (PET) tracer in men with newly diagnosed prostate cancer and those with a recurrence of prostate cancer after having undergone previous prostate cancer treatment. Under the guidance of Judith Rose M.D., Medical Director of PET/CT and Clinical Research for RadNet, and in conjunction with Dr. David Josephson M.D. of Tower Urology, and Blue Earth Diagnostics.
MRI First for Prostate Cancer
A new study shows that performing MRI scans before biopsy on men with high PSA scores could reduce prostate cancer death rates by almost 20%.
Make a Difference in the Life of the Man You Love
Did you know that prostate cancer is the second most common cancer in men? And yet, it is highly treatable if detected early. Likewise, Benign Prostate Hyperplasia (BPH), affects about 50 percent of men between the ages of 51 and 60, and up to 90 percent of men older than 90.
WEBINAR: New Advances in Prostate Imaging and Image Guided Therapies
Presentation and Q&A by Dr. Robert Princenthal
RadNet, under the direction of Dr. Princenthal, is launching a new Tulsa Prostate Treatment Program at their West Hills location. This will be the first commercially available Tulsa Pro treatment facility in the western United States. Tulsa Pro offers an incision-free, radiation-free solution for prostate disease and it is designed to preserve men’s functional abilities. Within the next several months, the Tulsa Pro treatment will also be available at one of RadNet’s Orange County locations.
Main talking points: